The bill establishes a new section in Florida law, 381.73531, focused on obesity treatment and diabetes prevention. It mandates the Agency for Health Care Administration to provide coverage for various treatments related to obesity, including intensive health behavior and lifestyle treatment, metabolic and bariatric surgery, and FDA-approved obesity medications. The bill specifies that coverage criteria for these medications cannot be more restrictive than the FDA-approved indications. Additionally, it allows for the provision of these services through telehealth and requires the agency to adopt rules to implement these provisions while ensuring that medical necessity determinations align with those for other covered conditions.

Furthermore, the bill requires the agency to cover a diabetes prevention program, with Medicaid reimbursement starting on July 1, 2025, for eligible enrollees who have not previously participated in the program. The Department of Health is also authorized to apply for a state plan amendment if necessary to facilitate the implementation of these provisions. The effective date for the bill is set for July 1, 2025.